HM Payson & Co
- SEC CIK
- 0000928052
- Latest filing
- Jul 17, 2026
RCUS holding history
Arcus Biosciences, Inc. in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RCUS overviewAll 13F holders of RCUSFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,700
- Value
- $52.4K
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,700 | $52.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 1,700 | $36.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 1,700 | $40.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 1,700 | $23.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 1,700 | $13.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 1,700 | $13.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 1,700 | $25.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 1,700 | $26.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 1,700 | $25.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 1,700 | $32.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 1,700 | $32.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 1,700 | $30.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 1,700 | $34.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 1,700 | $31.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 1,700 | $35.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 1,700 | $44.0K | <0.1% | +700+70.0% | Added | Holders |
| Q2 2022 | 1,000 | $25.0K | <0.1% | +1,000 | New | Holders |